FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4376058382> ?p ?o ?g. }

• W4376058382 abstract "<sec> <title>BACKGROUND</title> Dengue fever can progress to dengue hemorrhagic fever (DHF), a more serious and occasionally fatal form of the disease. Indicators of serious disease arise about the time the fever begins to reduce (typically 3 to 7 days following symptom onset). There are currently no effective antivirals available. Drug repurposing is an emerging drug discovery process for rapidly developing effective DHF therapies. Through network pharmacology modeling, several US Food and Drug Administration (FDA)-approved medications have already been researched for various viral outbreaks. </sec> <sec> <title>OBJECTIVE</title> We aimed to identify potentially repurposable drugs for DHF among existing FDA-approved drugs for viral attacks, symptoms of viral fevers, and DHF. </sec> <sec> <title>METHODS</title> Using target identification databases (GeneCards and DrugBank), we identified human–DHF virus interacting genes and drug targets against these genes. We determined hub genes and potential drugs with a network-based analysis. We performed functional enrichment and network analyses to identify pathways, protein-protein interactions, tissues where the gene expression was high, and disease-gene associations. </sec> <sec> <title>RESULTS</title> Analyzing virus-host interactions and therapeutic targets in the human genome network revealed 45 repurposable medicines. Hub network analysis of host-virus-drug associations suggested that aspirin, captopril, and rilonacept might efficiently treat DHF. Gene enrichment analysis supported these findings. According to a Mayo Clinic report, using aspirin in the treatment of dengue fever may increase the risk of bleeding complications, but several studies from around the world suggest that thrombosis is associated with DHF. The human interactome contains the genes <i>prostaglandin-endoperoxide synthase 2</i> (<i>PTGS2</i>), <i>angiotensin converting enzyme (ACE)</i>, and <i>coagulation factor II, thrombin</i> (<i>F2)</i>, which have been documented to have a role in the pathogenesis of disease progression in DHF, and our analysis of most of the drugs targeting these genes showed that the hub gene module (human-virus-drug) was highly enriched in tissues associated with the immune system (<i>P</i>=7.29 × 10^–24) and human umbilical vein endothelial cells (<i>P</i>=1.83 × 10^–20); this group of tissues acts as an anticoagulant barrier between the vessel walls and blood. Kegg analysis showed an association with genes linked to cancer (<i>P</i>=1.13 × 10^–14) and the advanced glycation end products–receptor for advanced glycation end products signaling pathway in diabetic complications (<i>P</i>=3.52 × 10^–14), which indicates that DHF patients with diabetes and cancer are at risk of higher pathogenicity. Thus, gene-targeting medications may play a significant part in limiting or worsening the condition of DHF patients. </sec> <sec> <title>CONCLUSIONS</title> Aspirin is not usually prescribed for dengue fever because of bleeding complications, but it has been reported that using aspirin in lower doses is beneficial in the management of diseases with thrombosis. Drug repurposing is an emerging field in which clinical validation and dosage identification are required before the drug is prescribed. Further retrospective and collaborative international trials are essential for understanding the pathogenesis of this condition. </sec>" @default.
• W4376058382 created "2023-05-11" @default.
• W4376058382 creator A5012601028 @default.
• W4376058382 creator A5039617672 @default.
• W4376058382 creator A5054551173 @default.
• W4376058382 creator A5060149617 @default.
• W4376058382 creator A5062040751 @default.
• W4376058382 creator A5072270951 @default.
• W4376058382 date "2022-02-15" @default.
• W4376058382 modified "2023-10-18" @default.
• W4376058382 title "The Identification of Potential Drugs for Dengue Hemorrhagic Fever: Network-Based Drug Reprofiling Study (Preprint)" @default.
• W4376058382 cites W1971937094 @default.
• W4376058382 cites W1973576889 @default.
• W4376058382 cites W1983907306 @default.
• W4376058382 cites W2025844353 @default.
• W4376058382 cites W2077923150 @default.
• W4376058382 cites W2078414627 @default.
• W4376058382 cites W2097852545 @default.
• W4376058382 cites W2159675211 @default.
• W4376058382 cites W2170146596 @default.
• W4376058382 cites W2171707538 @default.
• W4376058382 cites W2474747771 @default.
• W4376058382 cites W2501497123 @default.
• W4376058382 cites W2602102858 @default.
• W4376058382 cites W2766967608 @default.
• W4376058382 cites W2808004873 @default.
• W4376058382 cites W2915216906 @default.
• W4376058382 cites W2950420258 @default.
• W4376058382 cites W2988387420 @default.
• W4376058382 cites W3011072970 @default.
• W4376058382 cites W3087136699 @default.
• W4376058382 cites W3107503376 @default.
• W4376058382 cites W3127311830 @default.
• W4376058382 cites W3145969289 @default.
• W4376058382 cites W3210331473 @default.
• W4376058382 doi "https://doi.org/10.2196/preprints.37306" @default.
• W4376058382 hasPublicationYear "2022" @default.
• W4376058382 type Work @default.
• W4376058382 citedByCount "0" @default.
• W4376058382 crossrefType "posted-content" @default.
• W4376058382 hasAuthorship W4376058382A5012601028 @default.
• W4376058382 hasAuthorship W4376058382A5039617672 @default.
• W4376058382 hasAuthorship W4376058382A5054551173 @default.
• W4376058382 hasAuthorship W4376058382A5060149617 @default.
• W4376058382 hasAuthorship W4376058382A5062040751 @default.
• W4376058382 hasAuthorship W4376058382A5072270951 @default.
• W4376058382 hasConcept C103637391 @default.
• W4376058382 hasConcept C116675565 @default.
• W4376058382 hasConcept C126322002 @default.
• W4376058382 hasConcept C155261790 @default.
• W4376058382 hasConcept C159047783 @default.
• W4376058382 hasConcept C2777494893 @default.
• W4376058382 hasConcept C2779134260 @default.
• W4376058382 hasConcept C2779635636 @default.
• W4376058382 hasConcept C2780035454 @default.
• W4376058382 hasConcept C524204448 @default.
• W4376058382 hasConcept C533803919 @default.
• W4376058382 hasConcept C71924100 @default.
• W4376058382 hasConcept C98274493 @default.
• W4376058382 hasConceptScore W4376058382C103637391 @default.
• W4376058382 hasConceptScore W4376058382C116675565 @default.
• W4376058382 hasConceptScore W4376058382C126322002 @default.
• W4376058382 hasConceptScore W4376058382C155261790 @default.
• W4376058382 hasConceptScore W4376058382C159047783 @default.
• W4376058382 hasConceptScore W4376058382C2777494893 @default.
• W4376058382 hasConceptScore W4376058382C2779134260 @default.
• W4376058382 hasConceptScore W4376058382C2779635636 @default.
• W4376058382 hasConceptScore W4376058382C2780035454 @default.
• W4376058382 hasConceptScore W4376058382C524204448 @default.
• W4376058382 hasConceptScore W4376058382C533803919 @default.
• W4376058382 hasConceptScore W4376058382C71924100 @default.
• W4376058382 hasConceptScore W4376058382C98274493 @default.
• W4376058382 hasLocation W43760583821 @default.
• W4376058382 hasOpenAccess W4376058382 @default.
• W4376058382 hasPrimaryLocation W43760583821 @default.
• W4376058382 hasRelatedWork W1995517874 @default.
• W4376058382 hasRelatedWork W2008026220 @default.
• W4376058382 hasRelatedWork W2011714939 @default.
• W4376058382 hasRelatedWork W2166268994 @default.
• W4376058382 hasRelatedWork W2308586264 @default.
• W4376058382 hasRelatedWork W3042757195 @default.
• W4376058382 hasRelatedWork W3098921675 @default.
• W4376058382 hasRelatedWork W3120208084 @default.
• W4376058382 hasRelatedWork W3213709983 @default.
• W4376058382 hasRelatedWork W4223628721 @default.
• W4376058382 isParatext "false" @default.
• W4376058382 isRetracted "false" @default.
• W4376058382 workType "article" @default.